Oil Plunges Back To Draghi Lows
Mar 15, 2016
Jeremy Parkinson
Finance
Just as we saw with the stock market following Draghi’s December disappointment dead-cat-bounce, WTI Crude has collapsed back to post-Draghi lows, erasing all the WTF bounce from Friday. The driver – aside from the fact that there was no driver of the ramp – appears to be comments from Emirates Bank on the resilience of US shale […]
Weekly Forex Technical Outlook – 15th March
Mar 15, 2016
Jeremy Parkinson
Finance
EUR/USD (1.11): The single currency has started to ease back following the post-ECB rally. Failure to test the upper resistance near 1.123 signals a potential pullback with the upside bias in the near term likely to stay intact. Support to the current declines come in at 1.095 – 1.10 region which is likely to be […]
USD/CAD – Trying To Find A Bottom As Key Support Approaches
Mar 15, 2016
Jeremy Parkinson
Finance
Two weeks ago I wrote that the USD/CAD would likely see more downside in the weeks ahead. At the time of that writing the pair was trading at 1.3517 some 350 pips over the low that we saw last week at 1.3166. We are now approaching an area of key support that should be key […]
Dollar Shortage Claims Another
Mar 15, 2016
Jeremy Parkinson
Finance
The Central Bank of Egypt auctioned $200 million at 8.85 per Egyptian pound rather than the prevailing 7.73. The inflationary move of devaluation is intended to help the country gain a more solid financial background due to a persisting “dollar shortage” that nobody seems to hold in much curiosity. Despite the fact that this is […]
E
Celator Pharmaceuticals Soars 300% On Positive Phase 3 Results In High-Risk AML Patients
Mar 15, 2016
Jeremy Parkinson
Finance
In after-hours trading on Monday shares of Celator Pharmaceuticals (CPXX) soared more than 300% as the company announced positive phase 3 results in a trial with patients with high-risk acute myeloid leukemia. The company’s injectable drug is known as VYXEOS or CPX-351. This drug was being compared to the standard of care regimen of cytarabine […]
Daily Market Analysis – 3/15/2016
Mar 15, 2016
Jeremy Parkinson
Finance
Video length: 00:01:37 During the day on Tuesday, it’s very likely that will have quite a bit of volatility because we have several different announcements coming out. We have the European employment numbers, the Core PPI, Core Retail Sales, and the Empire Stay Manufacturing Index out of the United States. Because of this, the market […]
Gold Gann Angle Update – March 14, 2016
Mar 15, 2016
Jeremy Parkinson
Finance
Gold Gann angles paint a nice picture. A pullback that so far has reacted to supporting 1×1 Blue Gann Angles. In short, we have a strong price reaction to GLD $100. Short covering or new investment, only future price action will confirm this. We shall have to watch the pullback nature of gold during the […]
Gold Daily And Silver Weekly Charts – FOMC Announcement On Wednesday The 16th
Mar 15, 2016
Jeremy Parkinson
Finance
Monday was a lightly traded day, with plenty of antics as the markets wait for something to act on, and if not, then anything the Fed might have to say on Wednesday. The US dollar was a little higher, and the precious metals moved a little lower in a fairly deliberate two step. It was […]
E
The Battlegrounds Are Fluid
Mar 14, 2016
Jeremy Parkinson
Finance
The battlegrounds are fluid as multiple dynamics are going on in this world; with the outcomes hard to ascertain. Not to mention GAAP vs Non-GAAP earnings show an incredible divergence. Some believe an Election trend toward Trump is a potential negative; others see Trump or Clinton as neutral for markets, while Sanders would be bearish. Trump’s economics […]
Monday Movers In The Biotech Bear Market: ALNY, GILD, GWPH
Mar 14, 2016
Jeremy Parkinson
Finance
Look for Value + Growth Picks in a Biotech Bear Market Review our assumptions from previous posts: Biotech remains in a bear market so sector plays may not work. Stock picking and trading are the favored tactics in this market. New portfolio picks are larger caps for safety and growth (ABBV, BMY, GILD) and one […]